Indeed, our data not only confirmed TLR3 up-regulation in MG thymomas versus normal thymuses, but also demonstrated that the expression of this receptor was higher in thymomas from MG patients compared with non-MG. This evidence concerns the gene TLR3 and myasthenia gravis.